Cargando…
The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
BACKGROUND: Ovarian cancer kills approximately 15,000 women in the United States every year, and more than 140,000 women worldwide. Most deaths from ovarian cancer are caused by tumors of the serous histological type, which are rarely diagnosed before the cancer has spread. Rational design of a pote...
Autores principales: | Brown, Patrick O., Palmer, Chana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711307/ https://www.ncbi.nlm.nih.gov/pubmed/19636370 http://dx.doi.org/10.1371/journal.pmed.1000114 |
Ejemplares similares
-
Diagnosis and natural history of preclinical and early inflammatory
bowel disease
por: Rodríguez-Lago, Iago, et al.
Publicado: (2020) -
Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
por: Lee, Sanghoon, et al.
Publicado: (2020) -
BRCA and Early Events in the Development of Serous Ovarian Cancer
por: George, Sophia H. L., et al.
Publicado: (2014) -
Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
por: Tamir, Ayala, et al.
Publicado: (2014) -
Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)